Sinopharm Group Co Ltd
SWB:X2S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Sinopharm Group Co Ltd (X2S) under the Base Case is EUR per share.
Compared with the current market price of 1.9565 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Sinopharm Group Does
Sinopharm Group is one of China’s biggest drug distributors and pharmacy operators. It buys medicines, vaccines, medical devices, and healthcare products from manufacturers, then moves them through its own wholesale and retail network to hospitals, clinics, pharmacies, and other healthcare buyers. It also sells over-the-counter products and runs pharmacy stores under its own retail banners.
- Headquarters
- China CN
- Employees
- 94 910
- IPO date
- Sep 23, 2009
Sinopharm Group has no economic moat
Sinopharm Group Co Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Sinopharm Group Co Ltd
What is the Intrinsic Value of one X2S stock?
The intrinsic value for Sinopharm Group Co Ltd (X2S) under the Base Case is EUR.
Is X2S stock undervalued or overvalued?
Compared with the current market price of 1.9565 EUR, the stock appears .
